Skip to main content
. 2018 Dec 31;8(1):e011028. doi: 10.1161/JAHA.118.011028

Table 6.

Multivariable‐Adjusted HR for Coronary Events by NGAL and Biomarkers of Potential Pathological Mechanisms*

Number of Events (%) Model 1* HR (95% CI) P Value Number of Events (%) Model 2* HR (95% CI) P Value
NGAL and hs‐cTnI
↓NGAL and ↓hs‐cTnI, n=319/229 42 (13.2) 1.00 (referent) 23 (10.0) 1.00 (referent)
↓NGAL and ↑hs‐cTnI, n=239/171 49 (20.5) 1.57 (1.01–2.43) 0.043 31 (19.3) 1.92 (1.09–3.37) 0.026
↑NGAL and ↓hs‐cTnI, n=240/177 49 (20.4) 1.51 (0.97–2.35) 0.069 32 (18.1) 1.76 (0.99–3.15) 0.056
↑NGAL and ↑hs‐cTnI, n=322/219 115 (35.7) 2.72 (1.84–4.03) <0.001 81 (37.0) 3.73 (2.24–6.22) <0.001
NGAL and homocysteine
↓NGAL and ↓homocysteine, n=273/216 39 (14.3) 1.00 (referent) 30 (13.2) 1.00 (referent)
↓NGAL and ↑homocysteine, n=175/138 32 (18.3) 1.25 (0.77–2.03) 0.365 19 (13.8) 0.85 (0.46–1.56) 0.602
↑NGAL and ↓homocysteine, n=172/135 38 (22.1) 1.47 (0.92–2.34) 0.104 30 (22.4) 1.56 (0.93–2.63) 0.095
↑NGAL and ↑homocysteine, n=285/211 88 (30.9) 1.97 (1.32–2.94) 0.001 64 (30.3) 1.85 (1.17–2.95) 0.009
NGAL and chronic kidney disease
↓NGAL and no CKD, n=403/306 61 (15.1) 1.00 (referent) 38 (12.4) 1.00 (referent)
↓NGAL and CKD, n=100/80 22 (22.0) 1.54 (0.92–2.59) 0.102 16 (20.0) 1.56 (0.84–2.90) 0.161
↑NGAL and no CKD, n=290/205 66 (22.8) 1.57 (1.09–2.24) 0.014 45 (22.0) 1.78 (1.15–2.77) 0.010
↑NGAL and CKD, n=223/165 88 (39.5) 2.99 (2.14–4.18) <0.001 89 (39.4) 3.22 (2.11–4.92) <0.001
*

Cox regression models were adjusted for conventional cardiovascular risk factors (Model 1 including age, and treatment code [calcium or placebo] or Model 2 including age, total cholesterol, high‐density lipoprotein cholesterol, current smoking, systolic blood pressure, prescription of antihypertensive medications, diabetes mellitus, and treatment code [calcium or placebo]). ↓=Less than the median value and ↑ greater than or equal to the median value. CKD indicates chronic kidney disease; HR, hazard ratio; hs‐cTnI, high‐sensitivity cardiac troponin I; NGAL, neutrophil gelatinase‐associated lipocalin.

*

Homocysteine only measured in 905 women.